Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

I-A/I-E Rat anti-Mouse, BB515, Clone: 2G9, BD

Rat Monoclonal Antibody

Manufacturer:  BD Biosciences 565254

Catalog No. BDB565254


Add to cart

Description

Description

The 2G9 antibody reacts with the I-Ad and I-Ed MHC class II alloantigens. It also reacts with transfectants expressing I-Eb and I-Ek and with cells from mice of the H-2p and H-2q haplotypes. This antibody is non-reactive with cells from SJL (H-2s) and NOD (H-2g7) mice. Flow cytometric analysis indicates that the 2G9 and M5/114.15.2 (Cat. No. 556999, for purified mAb) monoclonal antibodies have comparable reactivity on cells from mice with I-Ab, I-Ad, I-Aq, I-Ed, and I-Ek alloantigens.

The antibody was conjugated to BD Horizon BB515 which was developed exclusively by BD Biosciences. With an excitation max of 490nm and an emission max of 515nm, BD Horizon BB515 can be excited by the 488nm laser and detected in a standard FITC set (e.g. 530/30-nm filter). This dye provides a much brighter alternative to FITC with less spillover into the PE detector.

Specifications

Specifications

I-A/I-E
2G9
BB515
Aqueous buffered solution containing ≤0.09% sodium azide
Rat
IgG2a, κ
RUO
Primary
Murine
Flow Cytometry
0.2mg/mL
H-2I; Ia Ag; I-Ad, I-Ed, I-Eb, and I-Ek MHC class II alloantigens
Affinity purified
BALB/c mouse epidermal Langerhans cells
0.1mg
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Monoclonal
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit